Saul Lowitt

776 total citations
25 papers, 625 citations indexed

About

Saul Lowitt is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Saul Lowitt has authored 25 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Saul Lowitt's work include Pharmacogenetics and Drug Metabolism (4 papers), Pain Mechanisms and Treatments (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Saul Lowitt is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Pain Mechanisms and Treatments (3 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Saul Lowitt collaborates with scholars based in United States and Italy. Saul Lowitt's co-authors include John I. Malone, Andor Szentivanyi, Joseph F. Williams, Jan K. Korthals, Gail Ironson, James M. Sherman, William R. Cook, Allen W. Root, Mohammad A. Sabir and Robert V. Farese and has published in prestigious journals such as Diabetes Care, PEDIATRICS and Diabetes.

In The Last Decade

Saul Lowitt

24 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saul Lowitt United States 14 157 124 107 90 84 25 625
Héctor Orrego Canada 20 100 0.6× 183 1.5× 45 0.4× 130 1.4× 90 1.1× 35 1.3k
A. Gougoux Canada 14 169 1.1× 342 2.8× 106 1.0× 71 0.8× 69 0.8× 58 852
I. Antonipillai United States 17 116 0.7× 314 2.5× 104 1.0× 314 3.5× 43 0.5× 34 958
Y Orita Japan 13 71 0.5× 299 2.4× 203 1.9× 45 0.5× 50 0.6× 35 685
M. D. Bailie United States 17 148 0.9× 200 1.6× 224 2.1× 107 1.2× 17 0.2× 35 767
Nobuo Shimojo Japan 16 82 0.5× 126 1.0× 197 1.8× 80 0.9× 40 0.5× 33 787
Jyotirmoy Nandi United States 14 146 0.9× 172 1.4× 101 0.9× 56 0.6× 37 0.4× 33 675
Neil I. Kaminsky United States 9 141 0.9× 271 2.2× 144 1.3× 148 1.6× 34 0.4× 13 866
Tsutomu Takahashi Japan 17 121 0.8× 219 1.8× 125 1.2× 49 0.5× 37 0.4× 58 775
Wieslaw Bochenek United States 19 183 1.2× 142 1.1× 91 0.9× 90 1.0× 84 1.0× 54 983

Countries citing papers authored by Saul Lowitt

Since Specialization
Citations

This map shows the geographic impact of Saul Lowitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saul Lowitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saul Lowitt more than expected).

Fields of papers citing papers by Saul Lowitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saul Lowitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saul Lowitt. The network helps show where Saul Lowitt may publish in the future.

Co-authorship network of co-authors of Saul Lowitt

This figure shows the co-authorship network connecting the top 25 collaborators of Saul Lowitt. A scholar is included among the top collaborators of Saul Lowitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saul Lowitt. Saul Lowitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malone, John I., et al.. (1996). The effects of acetyl-l-carnitine and sorbinil on peripheral nerve structure, chemistry, and function in experimental diabetes. Metabolism. 45(7). 902–907. 13 indexed citations
2.
Malone, John I., et al.. (1996). PREPUBERTAL HYPERGLYCEMIA CAUSES NERVE DAMAGE. † 538. Pediatric Research. 39. 92–92. 1 indexed citations
3.
Lowitt, Saul, et al.. (1995). Acetyl-l-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism. 44(5). 677–680. 74 indexed citations
4.
Malone, John I. & Saul Lowitt. (1992). Measurements of tissue sorbitol in diabetes mellitus: Enzyme method versus gas-liquid chromatography. Metabolism. 41(2). 224–227. 16 indexed citations
5.
Malone, John I., et al.. (1992). Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-L-carnitine.. PubMed. 12(5-6). 237–41. 12 indexed citations
6.
Gieron, Maria A., John I. Malone, Saul Lowitt, & Jan K. Korthals. (1991). Improvement in peripheral nerve function after one year of Sorbinil. Neuroreport. 2(6). 348–350. 7 indexed citations
7.
Malone, John I., Saul Lowitt, & William R. Cook. (1990). Nonosmotic Diabetic Cataracts. Pediatric Research. 27(3). 293–296. 50 indexed citations
8.
Wiener, Doris, et al.. (1990). Multiparametric analysis of peripheral blood in the normal pediatric population by flow cytometry. Journal of Clinical Laboratory Analysis. 4(3). 175–179. 42 indexed citations
9.
Polson, James B., Richard F. Lockey, Samuel C. Bukantz, et al.. (1988). Effects of ketotifen on the responsiveness of peripheral blood lymphocyte β-adrenergic receptors. International Journal of Immunopharmacology. 10(6). 657–663. 3 indexed citations
10.
Biersdorf, William R., John I. Malone, Peter R. Pavan, & Saul Lowitt. (1988). Cone electroretinograms and visual acuities of diabetic patients on Sorbinil treatment. Documenta Ophthalmologica. 69(3). 247–254. 14 indexed citations
11.
Malone, John I., et al.. (1986). Hypercalciuria, Hyperphosphaturia, and Growth Retardation in Children With Diabetes Mellitus. PEDIATRICS. 78(2). 298–304. 34 indexed citations
12.
Sherman, James M., et al.. (1986). Factors influencing acquired subgottic stenosis in infants. The Journal of Pediatrics. 109(2). 322–327. 92 indexed citations
13.
Malone, John I., et al.. (1986). Comparison of Insulin Levels After Injection by Jet Stream and Disposable Insulin Syringe. Diabetes Care. 9(6). 637–640. 29 indexed citations
14.
Malone, John I., Shirish C. Shah, Dorothy I. Shulman, et al.. (1984). HYPERCALCIURIA AND GROWTH FAILURE IN CHILDREN WITH DIABETES. Pediatric Research. 18. 296A–296A.
15.
Lowitt, Saul, Robert V. Farese, Mohammad A. Sabir, & Allen W. Root. (1982). RAT LEYDIG CELL PHOSPHOLIPID CONTENT IS INCREASED BY LUTEINIZING HORMONE AND 8-BROMO-CYCLIC AMP. Endocrinology. 111(4). 1415–1417. 37 indexed citations
16.
Williams, Joseph F., et al.. (1981). Depression of hepatic mixed-function oxidase activity by B. pertussis in splenectomized and athymic nude mice. Immunopharmacology. 3(2). 101–106. 6 indexed citations
17.
Lowitt, Saul, Andor Szentivanyi, & Joseph F. Williams. (1981). Endotoxin inhibition of dexamethasone induction of tryptophan oxygenase in suspension culture of isolated rat parenchymal cells. Biochemical Pharmacology. 30(14). 1999–2006. 7 indexed citations
18.
Williams, Joseph F., Saul Lowitt, & Andor Szentivanyi. (1980). Involvement of a heat-stable and heat-labile component of Bordetella pertussis in the depression of the murine hepatic mixed-function oxidase system. Biochemical Pharmacology. 29(11). 1483–1490. 14 indexed citations
19.
Williams, Joseph F., Saul Lowitt, & Andor Szentivanyi. (1980). Endotoxin depression of hepatic mixed function oxidase system in C3H/HeJ and C3H/HeN mice. Immunopharmacology. 2(4). 285–291. 13 indexed citations
20.
Williams, Joseph F., Saul Lowitt, & Andor Szentivanyi. (1979). Effects of phenobarbital and 3-methylcholanthrene pretreatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats. Biochemical Pharmacology. 28(19). 2935–2940. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026